Your browser doesn't support javascript.
loading
Impacts of Early Guideline-Directed 21-Gene Recurrence Score Testing on Adjuvant Therapy Decision Making.
Dzimitrowicz, Hannah; Mougalian, Sarah; Storms, Sherri; Hurd, Sandra; Chagpar, Anees B; Killelea, Brigid K; Horowitz, Nina R; Lannin, Donald R; Harigopal, Malini; Hofstatter, Erin; DiGiovanna, Michael P; Adelson, Kerin B; Silber, Andrea; Abu-Khalaf, Maysa; Chung, Gina; Zaheer, Wajih; Abdelghany, Osama; Hatzis, Christos; Pusztai, Lajos; Sanft, Tara B.
Affiliation
  • Dzimitrowicz H; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Mougalian S; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Storms S; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Hurd S; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Chagpar AB; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Killelea BK; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Horowitz NR; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Lannin DR; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Harigopal M; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Hofstatter E; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • DiGiovanna MP; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Adelson KB; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Silber A; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Abu-Khalaf M; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Chung G; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Zaheer W; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Abdelghany O; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Hatzis C; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Pusztai L; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Sanft TB; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
J Oncol Pract ; 13(12): e1012-e1020, 2017 12.
Article in En | MEDLINE | ID: mdl-29048991
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Testing / Chemotherapy, Adjuvant / Neoplasm Recurrence, Local Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: J Oncol Pract Year: 2017 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Testing / Chemotherapy, Adjuvant / Neoplasm Recurrence, Local Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: J Oncol Pract Year: 2017 Type: Article